23andMe sale grafts a happy ending on to a glum tale
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Genetic testing company 23andMe’s
23andMe sold out of bankruptcy to Regeneron
[ad_1] Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. US drugmaker Regeneron has
23andMe files for bankruptcy protection as CEO steps down
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Genetics testing company 23andMe
